Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

State Drug Advertising Laws Foreshadow Future Device Regulation

This article was originally published in The Pink Sheet Daily

Executive Summary

Some state lawmakers contend that industry's voluntary code of ethics is insufficient, according to Kyphon's chief compliance officer.

You may also be interested in...



J&J Sues Boston Scientific, Abbott For $5.5 Bil For Breach Of Contract

After losing bidding war for Guidant, J&J charges winning firms with using leaked information.

FDA Official Distinguishes Scientific Exchange From Off-Label Promotion

Agency compliance head Tim Ulatowski says he's not concerned about the scientific exchange of information on products.

Supreme Court Considers Patentability Of Basic Scientific Relationship

Defendant Metabolite argued that validity of patenting a natural phenomenon would have broader implications within the pharmaceutical, device and diagnostics industries.

Topics

UsernamePublicRestriction

Register

ID1131516

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel